Advances in therapeutic CRISPR/Cas9 genome editing

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116

Multiplex Genome Engineering Using CRISPR/Cas Systems

Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339

RNA-Guided Human Genome Engineering via Cas9

Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210

The new frontier of genome engineering with CRISPR-Cas9

Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium

Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299

High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells

Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292

In vivo genome editing using Staphylococcus aureus Cas9

Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687

Improvement of Bacterial Blight Resistance in Two Conventionally Cultivated Rice Varieties by Editing the Noncoding Region

Li, C., Zhou, L., Wu, B., Li, S., Zha, W., Li, W., Zhou, Z., Yang, L., Shi, L., Lin, Y., et al. (2022) · Cells · doi:10.3390/cells11162535 · Cited by 20

Baculovirus-based genome editing in primary cells

Mansouri, M., Ehsaei, Z., Taylor, V., & Berger, P. (2017) · Plasmid · doi:10.1016/j.plasmid.2017.01.003 · Cited by 20

Gene delivery methods and genome editing of human pluripotent stem cells

Czerwińska, P., Mazurek, S., Kołodziejczak, I., & Wiznerowicz, M. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.01.007 · Cited by 20

Role of epigenetic regulation in diminished ovarian reserve

Chen, W. L., Dong, L., Wei, C., & Wu, H. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03301-8 · Cited by 21

Unraveling the future of genomics: CRISPR, single-cell omics, and the applications in cancer and immunology

Menon, A. V., Song, B., Chao, L., Sriram, D., Chansky, P. A., Bakshi, I., Ulianova, J., & Li, W. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1565387 · Cited by 21

Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells

Kissling, L., Monfort, A., Swarts, D. C., Wutz, A., & Jínek, M. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.028 · Cited by 17

Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours

Barszczewska-Pietraszek, G., Drzewiecka, M., Czarny, P. L., Skórski, T., & Śliwiński, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010319 · Cited by 19

The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs

Bayat, H., Omidi, M., Rajabibazl, M., Sabri, S., & Rahimpour, A. (2017) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1607.07005 · Cited by 18

Current Status of Nonviral Vectors for Gene Therapy in China

Liu, L., Yang, H. J., Men, K., He, Z., Luo, M., Qian, Z., Wei, X., & Wei, Y. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.226 · Cited by 18

Chimeric crRNAs with 19 DNA residues in the guide region show the retained DNA cleavage activity of Cas9 with potential to improve the specificity

Kim, H. Y., Kang, S. J., Jeon, Y., An, J., Park, J., Lee, H. J., Jang, J.-E., Ahn, J., Bang, D., Chung, H. S., et al. (2019) · Chemical Communications · doi:10.1039/c8cc08468h · Cited by 17

The impact of nucleosome structure on CRISPR/Cas9 fidelity

Handelmann, C. R., Tsompana, M., Samudrala, R., & Buck, M. J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad021 · Cited by 17

Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective

Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 21

Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology

Guitart, J., Johnson, J. L., & Chien, W. W. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.007 · Cited by 17

Gene Therapy: The View from NCATS

Brooks, P. J., Yang, N. N., & Austin, C. P. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.29018.pjb · Cited by 16

Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy

Shin, H., & Kim, J. (2022) · Chemical Communications · doi:10.1039/d1cc05999h · Cited by 14

Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature

Tafazoli, A., Behjati, F., Farhud, D. D., & Abbaszadegan, M. R. (2019) · Iranian Journal of Public Health · doi:10.18502/ijph.v48i3.878 · Cited by 15

Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2

Abbaszadeh‐Goudarzi, K., Nematollahi, M. H., Khanbabaei, H., Hosseini-Nave, H., Mirzaei, H. R., Pourghadamyari, H., & Sahebkar, A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666201009154517 · Cited by 24

Cas-based bacterial detection: recent advances and perspectives

Lan, H., Shu, W., Jiang, D., Yu, L., & Xu, G. (2024) · The Analyst · doi:10.1039/d3an02120c · Cited by 14

CRISPR-Cas9 in basic and translational aspects of cancer therapy

Salavatipour, M. S., Poursalehi, Z., Rouzbahani, N. H., Mohammadyar, S., & Vasei, M. (2024) · Bioimpacts · doi:10.34172/bi.2024.30087 · Cited by 14

Progranulin regulation of autophagy contributes to its chondroprotective effect in osteoarthritis

Pan, Y., Yang, Y., Fan, M., Chen, C., Jiang, R., Li, L., Xian, M., Kuang, B., Geng, N., Feng, N., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.05.031 · Cited by 14

Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies

Beghini, D. G., Horita, S. I. M., Cascabulho, C. M., Alves, L. A., & Henriques‐Pons, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155467 · Cited by 22

Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

Katta, M., Mathew, B. A., Chaturvedi, P., Ludhiadch, A., & Munshi, A. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06356-6 · Cited by 13

Genetically modified cell spheroids for tissue engineering and regenerative medicine

Jiang, Z., Xu, Y., Fu, M., Zhu, D., Li, N., & Yang, G. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.033 · Cited by 12

The Skeleton of Lateral Meningocele Syndrome

CANALIS, E. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.620334 · Cited by 13

Recent advances in the production, reprogramming, and application of CAR-T cells for treating hematological malignancies

Vandghanooni, S., Eskandani, M., Sanaat, Z., & Omidi, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121016 · Cited by 13

Global research trends in CRISPR-related technologies associated with extracellular vesicles from 2015 to 2022: a bibliometric, dynamic, and visualized study

Lin, J., Jia, S., Jiao, Z., Chen, J., Li, W., Cao, F., & Zhang, X. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00507-z · Cited by 13

The use of induced pluripotent stem cells for studying and treating optic neuropathies

Khan, S., Hung, S. S. C., & Wong, R. C. B. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000348 · Cited by 13

TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis

Wang, Y., Chen, Y., Li, C., Xiao, Z., Yuan, H., Zhang, Y., Pang, D., Tang, X., Li, M., & Ouyang, H. (2022) · Biology · doi:10.3390/biology11010141 · Cited by 13

Simultaneous generation of multi‐gene knockouts in human cells

Zhou, Y., Zhang, H., & Wei, W. (2016) · FEBS Letters · doi:10.1002/1873-3468.12469 · Cited by 12

Feasibility of implementing RPA coupled with CRISPR-Cas12a (RPA-Cas12a) for Hepatozoon canis detection in dogs

Paenkaew, S., Poommouang, A., Pradit, W., Chomdej, S., Nganvongpanit, K., Siengdee, P., & Buddhachat, K. (2024) · Veterinary Parasitology · doi:10.1016/j.vetpar.2024.110298 · Cited by 11

A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9

Cuculis, L., & Schroeder, C. M. (2017) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060816-101603 · Cited by 12

Correction of point mutations at the endogenous locus of the dihydrofolate reductase gene using repair-PolyPurine Reverse Hoogsteen hairpins in mammalian cells

Solé, A. S., Ciudad, C. J., Chasin, L. A., & Noé, V. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.04.002 · Cited by 11

Alternative RNA Splicing in the Retina: Insights and PerspectivesPreprint

Keuthan, C. J., Karma, S., & Zack, D. J. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041313 · Cited by 13

Myd88 Signaling Is Involved in the Inflammatory Response in LPS-Induced Mouse Epididymitis and Bone-Marrow-Derived Dendritic Cells

Liu, J., Wang, P., Zeng, Q., Chen, Y., Lyu, M., 李彦锋, Yeung, W. S. B., Chiu, P. C. N., Haidl, G., Allam, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097838 · Cited by 10

Genome-edited rabbits: Unleashing the potential of a promising experimental animal model across diverse diseases

Han, Y., 吉林大学动物科学学院人畜共患病研究教育部重点实验室, 吉. 长. 1., Zhou, J., Zhang, R., Liang, Y., Lai, L., Li, Z., 中国科学院再生生物学重点实验室、广东省干细胞与再生医学重点实验室、中国科学院广州生物医药与健康研究院华南干细胞生物学与再生医学研究所, 广., 广州再生医学与健康广东实验室(GRMH-GDL), 广. 广. 5., & 中国科学院干细胞与再生研究所, 北. 1. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.201 · Cited by 11

CRISPR-Cas9 Therapies in Experimental Mouse Models of Cancer

Estêvão, D., Costa, N. R., da Costa, R. M. G., & Medeiros, R. (2018) · Future Oncology · doi:10.2217/fon-2018-0028 · Cited by 10

A novel system for correcting large-scale chromosomal aberrations: ring chromosome correction via reprogramming into induced pluripotent stem cell (iPSC)

Kim, T. H., Plona, K. L., & Wynshaw-Boris, A. J. (2016) · Chromosoma · doi:10.1007/s00412-016-0621-6 · Cited by 10

Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer

Dhuri, A., Kanp, T., Rode, K., Bharath, M., Gupta, U., Guru, S. K., & Singh, P. K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106083 · Cited by 9

The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats

Tang, A., Zhu, M., Zhu, J., Zhang, D., Zhu, S., Meng, C., Li, C., & Liu, G. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126468 · Cited by 9

Knockout of cytidine monophosphate-N-acetylneuraminic acid hydroxylase in Chinese hamster ovary cells by CRISPR/Cas9-based gene-editing technology

Chai, Y., Cao, X.-X., Ge, M.-M., Mi, C., Guo, X. H., & Wang, T. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107663 · Cited by 9

Overexpression of Klotho gene using CRISPR/Cas9 induces apoptosis and inhibits cell motility in the human colorectal cancer cells

Soykan, M. N., & Güneş, S. (2024) · Biotechnology Journal · doi:10.1002/biot.202300496 · Cited by 9

CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss

Ryu, N., Kim, M.-A., Choi, D.-G., Kim, Y., Sonn, J. K., Lee, K.-Y., & Kim, U. (2019) · Gene · doi:10.1016/j.gene.2019.03.020 · Cited by 9

Progranulin, a moderator of estrogen/estrogen receptor α binding, regulates bone homeostasis through PERK/p-eIF2 signaling pathway

Yang, Y., Feng, N., Li, L., Jiang, R., Pan, Y., Geng, N., Fan, M., Li, X., & Guo, F. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02233-z · Cited by 9

Industrial Enzymes and Biocatalysis

Garske, A. L., Kapp, G., & McAuliffe, J. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-52287-6_28 · Cited by 9

Unlocking the potential of CRISPR-Cas9 for cystic fibrosis: A systematic literature review

Harris, H., & Kittur, J. (2025) · Gene · doi:10.1016/j.gene.2025.149257 · Cited by 9

Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability

Zhao, J., Ma, W., Zhong, Y., Deng, H., Zhou, B., Wu, Y., Yang, M., & Li, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.652392 · Cited by 8

What did CRISPR-Cas9 accomplish in its first 10 years?

Khlidj, Y. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030601 · Cited by 9

Mini-review on CRISPR-Cas9 and its potential applications to help controlling neglected tropical diseases caused by Trypanosomatidae

Minet, C., Thévenon, S., Chantal, I., Solano, P., & Berthier, D. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.02.030 · Cited by 8

Editing the Reactive Genome: Towards a Postgenomic Ethics of Germline Editing

Güttinger, S. (2019) · Journal of Applied Philosophy · doi:10.1111/japp.12367 · Cited by 11

Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis in Vitro

Inoue, M., Muta, K., Mohammed, A. F. A., Onodera, R., Higashi, T., Ouchi, K., Ueda, M., Ando, Y., Arima, H., Jono, H., et al. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00452 · Cited by 8

Analysis of microsatellite instability in CRISPR/Cas9 editing mice

Huo, X., Du, Y., Lü, J., Guo, M., Li, Z., Zhang, S., Li, X., Chen, Z., & Du, X. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.02.003 · Cited by 8

On recent advances in human engineering

Anton, R. (2016) · Politics and the Life Sciences · doi:10.1017/pls.2016.17 · Cited by 7

Chemical Approach to Biological Safety: Molecular‐Level Control of an Integrated Zinc Finger Nuclease

Németh, E., Asaka, M. N., Kato, K., Fábián, Z., Oostenbrink, C., Christensen, H. E. M., Nagata, K., & Gyurcsik, B. (2017) · ChemBioChem · doi:10.1002/cbic.201700420 · Cited by 7

Using CRISPR/Cas9 System to Knock out Exon 48 in DMD Gene

Dara, M., Razban, V., Talebzadeh, M., Moradi, S., & Dianatpour, M. (2021) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v13i2.5517 · Cited by 7

dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa

Wang, Q. K., Xu, X., Chen, S., Lu, R., Li, L., Lo, C., Liu, Z., Ning, K., Li, T., Kowal, T. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn7540 · Cited by 6

Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability

Schneider, I., & Zierz, S. (2016) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s72834 · Cited by 6

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Takahashi, H., Sharma, H., & Carninci, P. (2019) · Journal of Visualized Experiments · doi:10.3791/58627 · Cited by 6

Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective

Ilahibaks, N. F., Hulsbos, M. J., Lei, Z., Vader, P., & Sluijter, J. P. G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_20 · Cited by 7

Genome editing of immune checkpoints: CRISPR-mediated PD-1 inhibition in cancer

Mohammad, S. I. S., Kareem, A. K., Vasudevan, A., Rekha, M. M., Jabir, M. S., Nayak, P. P., AlKhafaje, Z., Arora, V., Kadhum, W. R., & Chennakesavulu, K. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152438 · Cited by 5

Teratogenicity

Garry, V. F., & Truran, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00062-7 · Cited by 5

Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids

Xiu, Z., Yang, Q., Xie, F., Han, F., He, W., & Liao, W. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241255470 · Cited by 5

Biotechnological applications of purine and pyrimidine deaminases

Arco, J. D., Acosta, J., & Fernández‐Lucas, J. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108473 · Cited by 4

The impact of epigenetic and epitranscriptomic modifications on Alzheimer’s disease: the mysteries of DNA, RNA, and histone methylation

Yao, M., Liu, A., Song, J., Xing, L., Huang, Y., & Li, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149852 · Cited by 4

Application of Gene Editing in Triple‐Negative Breast Cancer Research

Feng, S., Li, J., Yan, A., Zhu, X., Zhang, L., Tang, D., & Liu, L. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70044 · Cited by 4

Revolutionising Cardio-Oncology Care with Precision Genomics

Chong, J. H., Chuah, C. T. H., & Lee, C. G. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052052 · Cited by 5

Utilization of the retinal organoid model to evaluate the feasibility of genetic strategies to ameliorate retinal disease(s)

Kelley, R. A., & Wu, Z. (2023) · Vision Research · doi:10.1016/j.visres.2023.108269 · Cited by 4

Reviews of Science for Science Librarians: CRISPR-Cas9 Revolutionizes Gene Editing

Butler, K. (2016) · Science & Technology Libraries · doi:10.1080/0194262x.2016.1208135 · Cited by 4

A Multiplex CRISPR/Cas9 System for Use as an Anti-BmNPV TherapeuticPreprint

Dong, Z., Qi, Q., Hu, Z., Chen, P., Huang, L., Long, J., Tian, T., Lu, C., & Pan, M. (2018) · Preprints.org · doi:10.20944/preprints201811.0159.v1 · Cited by 4

Current approaches in CRISPR-Cas system for metabolic disorder

Arora, Y., Priya, Kumar, M., & Kumar, D. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.016 · Cited by 3

Tandem repeat disorders: from diagnosis to emerging therapeutic strategies

Moon, J. (2024) · encephalitis · doi:10.47936/encephalitis.2024.00122 · Cited by 4

A versatile two-dimensional liquid chromatography coupled to high-resolution mass spectrometry platform for unraveling chromatographic profiles of large synthetic oligonucleotides

Chen, B., Wei, B., Dai, L., Wang, J., Kou, D., & Zhang, K. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344218 · Cited by 4

Gene editing tools promote the development of chloroplast gene engineering

Xu, P., Zhao, C., Li, X., Li, S., Li, A., Zhao, J., Ma, A., Wang, Q., Guo, D., Zhou, J., et al. (2025) · Current Plant Biology · doi:10.1016/j.cpb.2025.100540 · Cited by 5

Multilayer regulation of CRISPR systems: integrating anti-CRISPR proteins, CRISPRi/a, and quorum sensing networks

Shan, C., Liu, C., Jin, C., & Tian, D. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1844116 · Cited by 3

Recent advances in CRISPR technology in the milieu of oral squamous cell carcinoma

Mukherjee, A. G., Renu, K., & Gopalakrishnan, A. V. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155860 · Cited by 3

Innovations in Molecular Biology-Cutting-Edge Breakthroughs in Molecular Genetics

Bhuvana, D. (2024) · Annals of Experimental and Molecular Biology · doi:10.23880/aemb-16000121 · Cited by 3

Silent angels the genetic and clinical aspects of Rett syndrome

Dziwota, E., Fałkowska, U., Adamczyk, K., Adamczyk, D., Stefańska, A., Pawęzka, J., & Olajossy, M. (2016) · Current Problems of Psychiatry · doi:10.1515/cpp-2016-0028 · Cited by 3

Editing the Genome Ex Vivo Stem Cell Therapy

Fan, Y., & Chan, J. K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0148-2 · Cited by 3

Cancer Diagnostics and Therapeutics

Prabhakar, U., Jayalakshmi, Y., & Wang, C. K. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_3 · Cited by 3

CRISPR in Medicine: A Systematic Review of Clinical Trials and Therapeutic Applications

Rahmanian, M., Khoshandam, M., Mousazadeh, M., Yang, P., Soltaninejad, H., Dehkordi, P. K., Sadeghizadeh, M., Goudarzi, M. T. H., Azimi, A. H., & Sheykhhasan, M. (2026) · Human Gene Therapy · doi:10.1177/10430342251409714 · Cited by 2

Introduction: regulation of biotechnology, between anxieties and trust in scientific progress

Herdegen, M. (2018) · Edward Elgar Publishing eBooks · doi:10.4337/9781786435965.00007 · Cited by 2

A utilização da técnica de CRISPR-CAS9 na Terapia Gênica

Bernardes, V. A., Rodrigues, G. M., Cabral, M. R. L., & Neres, L. L. F. G. (2021) · Research Society and Development · doi:10.33448/rsd-v10i14.21778 · Cited by 8

Genome Editing and Diabetic Cardiomyopathy

Kambis, T. N., & Mishra, P. K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_7 · Cited by 2

A NOTCH3 pathogenic variant influences osteogenesis and can be targeted by antisense oligonucleotides in induced pluripotent stem cells

CANALIS, E. M., Yu, J., Schilling, L., Jafar‐Nejad, P., & Carrer, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316644 · Cited by 2

CRISPR-Cas-Based Gene Therapy to Target Viral Infections

Hussein, M., Berkhout, B., & Herrera-Carrillo, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_5 · Cited by 2

Revolutions of CRISPR/Cas9 in modern era as genome editing tool

Ullah, A., Ahmed, H. G. M., Hasan, S. W., & Malik, A. (2020) · World Journal of Biology and Biotechnology · doi:10.33865/wjb.005.02.0301 · Cited by 2

An Introduction to Genome Editing Techniques

Munawar, N., & Ahmad, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6305-5_1 · Cited by 2

Novel Approaches to Program Cells to Differentiate into Cardiomyocytes in Myocardial Regeneration

Bonavida, V., Ghassemi, K., Ung, G. A., Inouye, K., Thankam, F. G., & Agrawal, D. K. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2312392 · Cited by 2

CAR-NK Cells as Promising Immune Therapeutics: Platforms and Current Progress

Salavatipour, M. S., Tavakoli, S., Tavoosi, S., Nodehi, M., Baghsheikhi, A. H., Vaezi, M., Verdi, J., Rahgozar, S., Barkhordar, M., & Ahmadvand, M. (2024) · International Journal of Cancer Management · doi:10.5812/ijcm-145431 · Cited by 2

Antibiyotiklere Alternatif Terapi: CRISPR-Cas antimikrobiyalleri

Taştan, C. (2020) · Gene Editing · doi:10.29228/genediting.41450 · Cited by 3

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Takahashi, H., Sharma, H., & Carninci, P. (2019) · Journal of Visualized Experiments · doi:10.3791/58627-v · Cited by 2

RNA and malaria pathogenesis

Saxena, M., & Arora, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817193-6.00007-8 · Cited by 1

Zastosowanie technologii CRISPR/Cas9 w leczeniu nowotworów

Romanowska, K., Ostapowicz, J., & Golusiński, W. (2022) · Letters in Oncology Science · doi:10.21641/los.2021.18.4.212 · Cited by 1

O impacto ambiental da edição genética no Brasil

Nohama, N., da Silva, J. S., & Simão-Silva, D. P. (2021) · Temáticas · doi:10.20396/tematicas.v29i58.15161 · Cited by 1

Teratogenicity

Garry, V. F., & Truran, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00062-x · Cited by 1

Introduction to Multiomics Technology

HajYasien, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-36502-7_1 · Cited by 1

CRISPR/Cas systems and techniques

Poonia, A. K., Batra, B., Lal, M. K., & Gahlaut, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18444-4.00003-x · Cited by 1

The CRISPR-Cas technology: trends in healthcare

Chawla, S., & Tyagi, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91808-4.00012-2 · Cited by 1

Chimeric crRNAs Retaining Activity of Cas12a with Potential to Improve Specificity

Park, J., Choi, J., Duong, M. T. H., Ahn, H., Hong, S. W., Hwang, G. T., An, J., Chung, H. S., & Ahn, D. (2020) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12109 · Cited by 1

CRISPR-CAS9 como ferramenta para edição do gene IT-15 na Doença de Huntington

de Godoy, L. A., & do Bomfim, F. R. C. (2020) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v10i4.1016 · Cited by 1

Looking back, moving forward

Ho, M., Ho, M. S. H., & Librach, C. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00015-3 · Cited by 1

Therapeutic applications of CRISPR RNA-guided genome editing

Koo, T., & Kim, J. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw032 · Cited by 24

CRISPR‐Cas9 : A New Tool for Gene Therapy

Sharma, S., Maiti, S., & Chakraborty, D. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0026629

Biology, Mechanism and Applications of CRISPR-Cas Immune System

Gök, Z. G., & Tunalı, B. Ç. (2016) · Uluslararası mühendislik araştırma ve geliştirme dergisi · doi:10.29137/umagd.346148 · Cited by 4

Therapeutic Genome Editing and In Vivo Delivery

Ramirez-Phillips, A. C., & Liu, D. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00613-w · Cited by 6

CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy

Zhang, X., Wang, L., Liu, M., & Li, D. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9057-2 · Cited by 28